Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

T-440: a new antiasthma drug candidate from Tanabe

Feb. 26, 1998

Animal study indicates efficacy of oral PAF antagonist in allergic rhinitis

Feb. 26, 1998

TRH ineffective as treatment for lung problems in premature infants

Feb. 25, 1998

First corticosteroid dry powder inhaler launched in the U.S.

Feb. 24, 1998

Evaluation of anti-IgE therapy in patients with seasonal allergic rhinitis

Feb. 24, 1998

TAU-284 awaiting approval in Japan

Feb. 23, 1998

Role of nonsteroidal antiinflammatory therapy in asthma

Feb. 20, 1998

Lisofylline enters pivotal testing for acute lung injury

Feb. 20, 1998

Independent evaluation committee requests additional OxSODrol data

Feb. 20, 1998

Enrollment complete in phase II trials for rPAF-AH

Feb. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...